CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SGEN

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
SGENPhase 2

Tucatinib Phase 2 Est. Readout

tucatinib
Q2 2027~Q
CT.gov
00%
Mar '27
SGENPhase 2

Tucatinib Phase 2 Est. Readout

tucatinib
Mar 2027~
CT.gov
00%
Competitive Landscape

1 competitor in Gastric Adenocarcinoma

View Full Landscape
Drug Information

Target Indication

Gastric Adenocarcinoma

Clinical Trial

NCT04499924

Last updated: 12/3/2025

Patent & Exclusivity
ActiveRLD

Latest Patent Expiry

Apr 27, 2038(11y 7m)

Patents Listed

7

Exclusivity

I-906ODE-309ODE-422

Application

NDA 213411
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.